Accomplished Pharmaceutical Analytical Professional with 10 years of experience in R&D Analytical and Quality Control Departments. Possesses strong expertise in the analysis of pharmaceutical raw materials, finished products, and stability samples, with proven problem-solving skills and the ability to work collaboratively in cross-functional teams. Highly experienced in analytical method validation using a wide range of laboratory instruments, including HPLC, GC, ICP-OES, Potentiometer, Particle Size Analyzer, and Dissolution Tester. Demonstrated success in leading high-stringency regulatory projects such as Azithromycin Tablets, Pregabalin Capsules, Atorvastatin Tablets, Montelukast Tablets, Lansoprazole Capsules, and 4-FDC Tablets, securing approvals from USFDA, EU GMP, and WHO. Recipient of the “Top Performance Award” at General Pharmaceuticals Ltd. for outstanding contributions during the EU GMP audit and for developing and implementing an in-house analytical equipment calibration procedure, achieving significant cost savings for the R&D Analytical Laboratory. Experienced in successfully handling global regulatory audits (USFDA, EU GMP, WHO, and others) while ensuring full compliance and driving continuous process improvement.